[ad_1] Results from the 8,179-subject REDUCE-IT study evaluation Amarin's (NASDAQ: AMRN) Vascepa (icosapent ethyl) in statin-treated adults with elevated cardiovascular (CV) risk showed a significant treatment effect. The data were presented at …
Read More »Amarin’s REDUCE-IT Trial: Something Fishy? – Amarin Corporation PLC (NASDAQ:AMRN)
[ad_1] Introduction I hope that everyone reading this has a baseline knowledge of Amarin (AMRN), its sole product Vascepa, and the REDUCE-IT cardiovascular outcomes trial, or CVOT. Further, presumably everyone is aware …
Read More »Ensco merges with Rowan: first impression – Ensco PLC (NYSE: ESV)
[ad_1] This week begins with huge news for the offshore drilling sector: Ensco (ESV) and Rowan (DRC). The companies decided to merge, subject to the vote of the shareholders. Under the terms …
Read More »Schroders Plc and Lloyds Banking Group under discussion for Wealth Management Agreement
[ad_1] (Reuters) – Asset Manager Schroders Plc (SDR.L) and Lloyds Banking Group (LLOY.L) said Sunday have discussed a wealth management alliance. PHOTO FILE: A man walks by the entrance of Lloyds Banking …
Read More »Schroders Plc and Lloyds Banking Group under discussion for Wealth Management Agreement
[ad_1] (Reuters) – Asset Manager Schroders Plc (SDR.L) and Lloyds Banking Group (LLOY.L) said Sunday have discussed a wealth management alliance. PHOTO FILE: A man walks by the entrance of Lloyds Banking …
Read More »Schroders Plc and Lloyds Banking Group under discussion for Wealth Management Agreement
[ad_1] (Reuters) – Asset Manager Schroders Plc (SDR.L) and Lloyds Banking Group (LLOY.L) said Sunday have discussed a wealth management alliance. PHOTO FILE: A man walks by the entrance of Lloyds Banking …
Read More »Is BP PLC a purchase? – The madman
[ad_1] As shareholders of BP (NYSE: BP) are well aware, the company has experienced many setbacks over the past decade. First, there was the catastrophic Deepwater Horizon oil spill in the Gulf …
Read More »Vascepa's result from Amarin marks an important milestone – Amarin Corporation PLC (NASDAQ: AMRN)
[ad_1] Recently, Amarin (AMRN) announced the results of its results study known as REDUCE-IT. The results of the test were very positive, as the main criterion was reached. This finding is important …
Read More »AstraZeneca's PT010 Offers Therapeutic Benefits in the Study of Advanced COPD – AstraZeneca Group plc (NYSE: AZN)
[ad_1] Results of a Phase 3 clinical trial, KRONOS, evaluating AstraZeneca (NYSE: AZN) triplet treatment with PT010 (budesonide / glycopyrronium / formoterol fumarate) compared to dual therapies Aerosphere Bevespi (glycopyrronium fumarate / …
Read More »Rhode Island pursues Big Oil against climate change – BP p.l.c. (NYSE: BP)
[ad_1] Rhode Island is suing several major oil companies, accusing them of contributing to climate change that damages infrastructure and coastal communities in the state. The lawsuit supports companies – including Exxon …
Read More »